ExLibris header image
SFX Logo
Title: PAINS in the Assay: Chemical Mechanisms of Assay Interference and Promiscuous Enzymatic Inhibition Observed during a Sulfhydryl-Scavenging HTS
Source:

Journal of Medicinal Chemistry [0022-2623] yr:2015


Collapse list of basic services Basic
Full text
Full text available via American Chemical Society Journals
GO
Document delivery
Request document via Library/Bibliothek GO
Users interested in this article also expressed an interest in the following:
1. Brady, Ryan M. "De-Novo Designed Library of Benzoylureas as Inhibitors of BCL-XL: Synthesis, Structural and Biochemical Characterization." Journal of medicinal chemistry 57.4 (2014): 1323-1343. Link to Full Text for this item Link to SFX for this item
2. Leeson, Paul D. "Molecular Property Design: Does Everyone Get It?" ACS medicinal chemistry letters 6.7 (2015): 722-725. Link to Full Text for this item Link to SFX for this item
3. Cavalli, P. "Molecular Dynamics Simulations and Kinetic Measurements to Estimate and Predict Protein–Ligand Residence Times." Journal of medicinal chemistry 59.15 (2016): 7167-7176. Link to Full Text for this item Link to SFX for this item
4. Leeson, P. "DRUG DISCOVERY Chemical beauty contest." Nature 481.7382 (2012): 455-456. Link to Full Text for this item Link to SFX for this item
5. Leeson, Paul D. "The influence of drug-like concepts on decision-making in medicinal chemistry." Nature reviews. Drug discovery 6.11 (2007): 881-890. Link to Full Text for this item Link to SFX for this item
6. Leeson, Paul D. "Drug-like properties: guiding principles for design - or chemical prejudice?" Drug discovery today. Technologies 1.3 (2004): 189-195. Link to SFX for this item
7. Lipinski, C A A. "Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings." Advanced drug delivery reviews 23.1 (2001): 3-26. Link to Full Text for this item Link to SFX for this item
8. Arrowsmith, Cheryl H. "Epigenetic protein families: a new frontier for drug discovery." Nature reviews. Drug discovery 11.5 (2012): 384-400. Link to SFX for this item
9. Bickerton, Gaia R. "Quantifying the chemical beauty of drugs." Nature chemistry 4.2 (2012): 90-98. Link to SFX for this item
10. Muegge, I. "Selection criteria for drug-like compounds." Medicinal research reviews 23.3 (2003): 302-21. Link to Full Text for this item Link to SFX for this item
11. Leeson, Paul D. "The influence of the 'organizational factor' on compound quality in drug discovery." Nature reviews. Drug discovery 10.10 (2011): 749-765. Link to SFX for this item
12. Di, Paul i. "Bridging solubility between drug discovery and development." Drug discovery today 17.9-10 (2011): 486-495. Link to SFX for this item
13. Jones, Alan W. "Early drug discovery and the rise of pharmaceutical chemistry." Drug testing and analysis 3.6 (2011): 337-344. Link to SFX for this item
14. Alaina, L. "Beauty contest." Nature 464.7287 (2010): 452-453. Link to Full Text for this item Link to SFX for this item
15. Matsson P, P. "How Big Is Too Big for Cell Permeability?" Journal of medicinal chemistry 60.5 (2017): 1662-1664. Link to Full Text for this item Link to SFX for this item
16. Tiwary, P. "How wet should be the reaction coordinate for ligand unbinding?" The Journal of chemical physics 145.5 (2016): 54113-54113. Link to Full Text for this item Link to SFX for this item
17. Blagg, J. "Physicochemical drug properties associated with in vivo toxicological outcomes: a review." Expert Opinion on Drug Metabolism and Toxicology 5.8 (2009): 921-931. Link to SFX for this item
18. Clardy Jon, J. "Lessons from natural molecules." Nature 432.7019 (2004): 829-837. Link to Full Text for this item Link to SFX for this item
View More...
View Less...
Select All Clear All

Expand list of advanced services Advanced
A service provided by the Library of the Wissenschaftspark Albert Einstein, Potsdam, Germany.
© 2005 SFX by Ex Libris Inc.